MULTICENTER STUDY OF ZOLEDRONIC ACID IN LUNG CANCER PATIENTS WITH BONE METASTASIS. THORACIC ONCOLOGY RESEARCH GROUP (TORG) 1017

被引：0

作者：

Hosomi, Yukio ^{[1
]}

Shibuya, Masahiko ^{[1
]}

Naoki, Katsuhiko ^{[2
]}

Soejima, Kenzo ^{[2
]}

Nogami, Naoyuki ^{[3
]}

Okamoto, Hiroaki ^{[4
]}

Nagase, Seisuke ^{[5
]}

Masuda, Noriyuki ^{[6
]}

Nishikawa, Masanori ^{[7
]}

Seto, Takashi ^{[8
]}

Minato, Kouichi ^{[9
]}

Takiguchi, Yuichi ^{[10
]}

Seki, Nobuhiko ^{[11
]}

Oshita, Fumihiro ^{[12
]}

Watanabe, Koshiro ^{[13
]}

机构：

[1] Komagome Hosp, Dept Thorac Oncol & Resp Med, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan

[2] Keio Univ, Sch Med, Tokyo 108, Japan

[3] Shikoku Canc Ctr, Dept Thorac Oncol, Matsuyama, Ehime, Japan

[4] Yokohama Municipal Citizens Hosp, Yokohama, Kanagawa, Japan

[5] Tokyo Med Univ, Tokyo 1608402, Japan

[6] Kitasato Univ, Sch Med, Tokyo, Japan

[7] Fujisawa City Hosp, Dept Resp Med, Fujisawa, Kanagawa, Japan

[8] Natl Kyushu Canc Ctr, Fukuoka, Japan

[9] Gunma Prefectural Canc Ctr, Ota, Gunma, Japan

[10] Chiba Univ, Grad Sch Med, Chiba, Japan

[11] Teikyo Univ, Sch Med, Dept Internal Med, Div Med Oncol, Tokyo, Japan

[12] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan

[13] Thorac Oncol Res Grp, Fukuoka, Japan

来源：

关键词：

Zoledronic Acid; Lung cancer; bone-modifying agents; metastatic bone disease;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.24-014

引用

页码：S1304 / S1304

页数：1